Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2024-2031

Report ID: 934618 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tablet
        1.2.3 Capsule
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Acute Ischemic Stroke Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Acute Ischemic Stroke Drugs Market Perspective (2016-2027)
    2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
        2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Acute Ischemic Stroke Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Acute Ischemic Stroke Drugs Industry Dynamic
        2.3.1 Acute Ischemic Stroke Drugs Market Trends
        2.3.2 Acute Ischemic Stroke Drugs Market Drivers
        2.3.3 Acute Ischemic Stroke Drugs Market Challenges
        2.3.4 Acute Ischemic Stroke Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue
        3.1.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue (2016-2021)
        3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Acute Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Acute Ischemic Stroke Drugs Revenue
    3.4 Global Acute Ischemic Stroke Drugs Market Concentration Ratio
        3.4.1 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Drugs Revenue in 2020
    3.5 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
    3.6 Key Players Acute Ischemic Stroke Drugs Product Solution and Service
    3.7 Date of Enter into Acute Ischemic Stroke Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Drugs Breakdown Data by Type
    4.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027)

5 Acute Ischemic Stroke Drugs Breakdown Data by Application
    5.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Acute Ischemic Stroke Drugs Market Size (2016-2027)
    6.2 North America Acute Ischemic Stroke Drugs Market Size by Type
        6.2.1 North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
        6.2.2 North America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
        6.2.3 North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
    6.3 North America Acute Ischemic Stroke Drugs Market Size by Application
        6.3.1 North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
        6.3.2 North America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
        6.3.3 North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
    6.4 North America Acute Ischemic Stroke Drugs Market Size by Country
        6.4.1 North America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
        6.4.2 North America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Acute Ischemic Stroke Drugs Market Size (2016-2027)
    7.2 Europe Acute Ischemic Stroke Drugs Market Size by Type
        7.2.1 Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
    7.3 Europe Acute Ischemic Stroke Drugs Market Size by Application
        7.3.1 Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
    7.4 Europe Acute Ischemic Stroke Drugs Market Size by Country
        7.4.1 Europe Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type
        8.2.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application
        8.3.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region
        8.4.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Acute Ischemic Stroke Drugs Market Size (2016-2027)
    9.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type
        9.2.1 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
    9.3 Latin America Acute Ischemic Stroke Drugs Market Size by Application
        9.3.1 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
    9.4 Latin America Acute Ischemic Stroke Drugs Market Size by Country
        9.4.1 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type
        10.2.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application
        10.3.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country
        10.4.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Acute Ischemic Stroke Drugs Introduction
        11.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.1.5 Sanofi Recent Development
    11.2 Biogen
        11.2.1 Biogen Company Details
        11.2.2 Biogen Business Overview
        11.2.3 Biogen Acute Ischemic Stroke Drugs Introduction
        11.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.2.5 Biogen Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Acute Ischemic Stroke Drugs Introduction
        11.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.3.5 Bayer Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Acute Ischemic Stroke Drugs Introduction
        11.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.4.5 Pfizer Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Acute Ischemic Stroke Drugs Introduction
        11.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Details
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Acute Ischemic Stroke Drugs Introduction
        11.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 Daiichi Sankyo
        11.7.1 Daiichi Sankyo Company Details
        11.7.2 Daiichi Sankyo Business Overview
        11.7.3 Daiichi Sankyo Acute Ischemic Stroke Drugs Introduction
        11.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.7.5 Daiichi Sankyo Recent Development
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Details
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.8.5 Bristol-Myers Squibb Recent Development
    11.9 Johnson＆Johnson
        11.9.1 Johnson＆Johnson Company Details
        11.9.2 Johnson＆Johnson Business Overview
        11.9.3 Johnson＆Johnson Acute Ischemic Stroke Drugs Introduction
        11.9.4 Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.9.5 Johnson＆Johnson Recent Development
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Acute Ischemic Stroke Drugs Introduction
        11.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.10.5 AstraZeneca Recent Development
    11.11 ZZ Biotech
        11.11.1 ZZ Biotech Company Details
        11.11.2 ZZ Biotech Business Overview
        11.11.3 ZZ Biotech Acute Ischemic Stroke Drugs Introduction
        11.11.4 ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.11.5 ZZ Biotech Recent Development
    11.12 NoNO Inc
        11.12.1 NoNO Inc Company Details
        11.12.2 NoNO Inc Business Overview
        11.12.3 NoNO Inc Acute Ischemic Stroke Drugs Introduction
        11.12.4 NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.12.5 NoNO Inc Recent Development
    11.13 Athersys
        11.13.1 Athersys Company Details
        11.13.2 Athersys Business Overview
        11.13.3 Athersys Acute Ischemic Stroke Drugs Introduction
        11.13.4 Athersys Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.13.5 Athersys Recent Development
    11.14 SanBio
        11.14.1 SanBio Company Details
        11.14.2 SanBio Business Overview
        11.14.3 SanBio Acute Ischemic Stroke Drugs Introduction
        11.14.4 SanBio Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
        11.14.5 SanBio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tablet
    Table 3. Key Players of Capsule
    Table 4. Key Players of Other
    Table 5. Global Acute Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Acute Ischemic Stroke Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Acute Ischemic Stroke Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Acute Ischemic Stroke Drugs Market Share by Regions (2016-2021)
    Table 9. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Acute Ischemic Stroke Drugs Market Share by Regions (2022-2027)
    Table 11. Acute Ischemic Stroke Drugs Market Trends
    Table 12. Acute Ischemic Stroke Drugs Market Drivers
    Table 13. Acute Ischemic Stroke Drugs Market Challenges
    Table 14. Acute Ischemic Stroke Drugs Market Restraints
    Table 15. Global Acute Ischemic Stroke Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Acute Ischemic Stroke Drugs Market Share by Players (2016-2021)
    Table 17. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2020)
    Table 18. Ranking of Global Top Acute Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Acute Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Acute Ischemic Stroke Drugs Product Solution and Service
    Table 22. Date of Enter into Acute Ischemic Stroke Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
    Table 26. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Acute Ischemic Stroke Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Acute Ischemic Stroke Drugs Revenue Market Share by Application (2016-2021)
    Table 30. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Acute Ischemic Stroke Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Sanofi Company Details
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Acute Ischemic Stroke Drugs Product
    Table 65. Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 66. Sanofi Recent Development
    Table 67. Biogen Company Details
    Table 68. Biogen Business Overview
    Table 69. Biogen Acute Ischemic Stroke Drugs Product
    Table 70. Biogen Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 71. Biogen Recent Development
    Table 72. Bayer Company Details
    Table 73. Bayer Business Overview
    Table 74. Bayer Acute Ischemic Stroke Drugs Product
    Table 75. Bayer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 76. Bayer Recent Development
    Table 77. Pfizer Company Details
    Table 78. Pfizer Business Overview
    Table 79. Pfizer Acute Ischemic Stroke Drugs Product
    Table 80. Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 81. Pfizer Recent Development
    Table 82. Roche Company Details
    Table 83. Roche Business Overview
    Table 84. Roche Acute Ischemic Stroke Drugs Product
    Table 85. Roche Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 86. Roche Recent Development
    Table 87. Boehringer Ingelheim Company Details
    Table 88. Boehringer Ingelheim Business Overview
    Table 89. Boehringer Ingelheim Acute Ischemic Stroke Drugs Product
    Table 90. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 91. Boehringer Ingelheim Recent Development
    Table 92. Daiichi Sankyo Company Details
    Table 93. Daiichi Sankyo Business Overview
    Table 94. Daiichi Sankyo Acute Ischemic Stroke Drugs Product
    Table 95. Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 96. Daiichi Sankyo Recent Development
    Table 97. Bristol-Myers Squibb Company Details
    Table 98. Bristol-Myers Squibb Business Overview
    Table 99. Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 100. Bristol-Myers Squibb Recent Development
    Table 101. Johnson＆Johnson Company Details
    Table 102. Johnson＆Johnson Business Overview
    Table 103. Johnson＆Johnson Acute Ischemic Stroke Drugs Product
    Table 104. Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 105. Johnson＆Johnson Recent Development
    Table 106. AstraZeneca Company Details
    Table 107. AstraZeneca Business Overview
    Table 108. AstraZeneca Acute Ischemic Stroke Drugs Product
    Table 109. AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 110. AstraZeneca Recent Development
    Table 111. ZZ Biotech Company Details
    Table 112. ZZ Biotech Business Overview
    Table 113. ZZ Biotech Acute Ischemic Stroke Drugs Product
    Table 114. ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 115. ZZ Biotech Recent Development
    Table 116. NoNO Inc Company Details
    Table 117. NoNO Inc Business Overview
    Table 118. NoNO Inc Acute Ischemic Stroke Drugs Product
    Table 119. NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 120. NoNO Inc Recent Development
    Table 121. Athersys Company Details
    Table 122. Athersys Business Overview
    Table 123. Athersys Acute Ischemic Stroke Drugs Product
    Table 124. Athersys Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 125. Athersys Recent Development
    Table 126. SanBio Company Details
    Table 127. SanBio Business Overview
    Table 128. SanBio Acute Ischemic Stroke Drugs Product
    Table 129. SanBio Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
    Table 130. SanBio Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Ischemic Stroke Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Tablet Features
    Figure 3. Capsule Features
    Figure 4. Other Features
    Figure 5. Global Acute Ischemic Stroke Drugs Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Diagnostic Centers Case Studies
    Figure 8. Others Case Studies
    Figure 9. Acute Ischemic Stroke Drugs Report Years Considered
    Figure 10. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Acute Ischemic Stroke Drugs Market Share by Regions: 2020 VS 2027
    Figure 13. Global Acute Ischemic Stroke Drugs Market Share by Regions (2022-2027)
    Figure 14. Global Acute Ischemic Stroke Drugs Market Share by Players in 2020
    Figure 15. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Drugs Revenue in 2020
    Figure 17. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
    Figure 18. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027)
    Figure 19. North America Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
    Figure 21. North America Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
    Figure 22. North America Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
    Figure 23. United States Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
    Figure 27. Europe Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
    Figure 28. Europe Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
    Figure 29. Germany Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Region (2016-2027)
    Figure 39. China Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
    Figure 47. Latin America Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
    Figure 48. Latin America Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
    Figure 49. Mexico Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
    Figure 55. Turkey Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 59. Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 60. Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 61. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 64. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 66. Johnson＆Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 67. AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 68. ZZ Biotech Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 69. NoNO Inc Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 70. Athersys Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 71. SanBio Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Biogen
Bayer
Pfizer
Roche
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb
Johnson＆Johnson
AstraZeneca
ZZ Biotech
NoNO Inc
Athersys
SanBio
Frequently Asked Questions
Acute Ischemic Stroke Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Ischemic Stroke Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Ischemic Stroke Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

P2P Carsharing

P2P stands for point-to-point.Point-to-point car sharing (sometimes called a distributed car shar ... Read More